BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 248 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,511,000 | -32.8% | 50,000 | -32.4% | 0.04% | -25.5% |
| Q2 2022 | $3,738,000 | -30.2% | 74,000 | +48.0% | 0.05% | -15.0% |
| Q4 2021 | $5,354,000 | -4.1% | 50,000 | -7.9% | 0.06% | -6.2% |
| Q3 2021 | $5,581,000 | +334.0% | 54,291 | +146.8% | 0.06% | -12.3% |
| Q1 2020 | $1,286,000 | -93.4% | 22,000 | -91.8% | 0.07% | -92.9% |
| Q3 2019 | $19,624,000 | +65.2% | 267,100 | +112.2% | 1.02% | +70.7% |
| Q2 2019 | $11,876,000 | +724.1% | 125,900 | +599.4% | 0.60% | +657.0% |
| Q1 2019 | $1,441,000 | – | 18,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |